Invention Grant
US08524665B2 Use of secretin in treatments of disorders associated with the amygdala
有权
使用促胰液素治疗与杏仁核有关的疾病
- Patent Title: Use of secretin in treatments of disorders associated with the amygdala
- Patent Title (中): 使用促胰液素治疗与杏仁核有关的疾病
-
Application No.: US10556134Application Date: 2004-05-13
-
Publication No.: US08524665B2Publication Date: 2013-09-03
- Inventor: Deborah A. Yurgelun-Todd , Perry F. Renshaw
- Applicant: Deborah A. Yurgelun-Todd , Perry F. Renshaw
- Applicant Address: US MA Belmont
- Assignee: The McLean Hospital Corporation
- Current Assignee: The McLean Hospital Corporation
- Current Assignee Address: US MA Belmont
- Agency: Clark & Elbing LLP
- International Application: PCT/US2004/015282 WO 20040513
- International Announcement: WO2004/100899 WO 20041125
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K31/00 ; A61K38/00 ; A61P25/18 ; A61P25/00 ; A61P25/24 ; C07D211/00 ; C07D307/00
Abstract:
In general, the present invention provides methods for treating disorders associated with the amygdala. The methods of treatment are based on the administration of a therapeutically effective amount of secretin to an individual suffering from a disorder associated with the amygdala, e.g., bipolar disorder or a substance use disorder.
Public/Granted literature
- US20070185018A1 Use of secretin in treatments of disorders associated with the amygdala Public/Granted day:2007-08-09
Information query
IPC分类:
